web analytics
Pharmaceutical product development experts essential in drug formulation | Velesco Pharma

Drug Formulation Development Case Studies | Velesco Pharma

Expert Solutions to Challenging Drug Formulation Projects


Challenge: drug formulation development using challenging vehicles


Velesco was contracted to create a common pharmaceutical formulation for four drug compounds to be dosed at multiple strengths using a clear aqueous vehicle.

Read the drug formulation development case study



Challenge: develop formulations for low solubility compounds with many delivery routes


Development of a drug formulation for a poorly soluble compound suitable for oral, intraperitoneal and intravenous use can be quite a challenge, but with our expertise, Velesco had the answer!

Read the drug formulation development case study



Challenge: high concentration pharmaceutical formulation development for compounds with low solubility using microemulsions


Velesco was asked to formulate a clear solution/microemulsion for a low solubility compound at a high concentration for an oral toxicity study, which was completed successfully.

Read the drug formulation development case study



Challenge: injectable formulations for poorly soluble drugs


Velesco developed an injectable formulation for a low solubility compound at a high dose using nucleation inhibitors.

Read the drug formulation development case study



Challenge: formulate drug product using active pharmaceutical ingredient (API) synthesized using different processes, addressing solubility issues.


Velesco was asked to formulate several different lots of material all displaying different characteristics.

Read the drug formulation development case study

News and Events

Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services

Read the Press Release!

Dave Barnes, Ph.D. CEO/CSO is a featured speaker for the webinar Topical Formulation: Selection of Excipients and Better Process Understanding for Success in Commercial Manufacturing. Webinar recording available now.

View Recording!

Newly Acquired DEA Analytical Laboratory License. We are licensed to use schedules 2, 2N, 3, 3N, 4, and 5.

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services.

Roundtable: M&A trends in CDMO - Molecule to Market

New Velesco Pharma clinical manufacturing facility begins operations.

Read the press release here.

Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.

Read the interview here.

Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group.

Read the press release here.

CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!

1 new job postings! Careers

Velesco's work published

Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.

Follow Velesco

LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter FB FindUsOnFacebook 100